Prospective observational longitudinal registry of patients with stable coronary artery disease

Status

Completed

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12609000883213

Acronym

CLARIFY

Enrollment

32703

Registered

2009-10-09

Start date

2010-02-18

Completion date

2010-06-28

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

CLARIFY is an international, observational, longitudianl registry in stable coronary artery disease outpatients with 5 year follow up. The registry will improve knowledge surrounding the care of outpatients with coronary artery disease.

Interventions

Observation of standard management of coronary artery disease patients over a 5 year period. Observations will be recorded at baseline and then every 12 months for 5 years. Data will be recorded detailing; patient demographics, cardiovascular risk factors, medical history, physical status (height, weight, electrocardiogram, blood test results for lipids and glucose) and current medications.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Outpatients with stable coronary artery disease proven by history of at least one of the following criteria: - documented myocardial infarction (>3months ago) - coronary angiography showing at least one coronary stenosis of more than 50% - chest pain with myocardial ischaemia proven by stress electrocardiogram, stress echocardiography or myocardial imaging - coronary artery bypass graft or percutaneous coronary intervention (>3 months ago)

Exclusion criteria

- Patients hospitalised for cardiovascular disease within last 3 months (including revascularisation) - Patients with planned revascularisation - Conditions hampering participation in the 5 year follow up, such as limited cooperation, limited legal capacity, serious non-cardiovascular disease or conditions interfering with life expectancy (cancer, drug abuse etc) or severe cardiovascular disease (advanced heart failure, severe valve disease, history of valve repair/replacement etc)

Outcome results